Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Robert M. Arusell"'
Autor:
Jan C. Buckner, Edward G. Shaw, Paul D. Brown, Sara Felten, Sandra Passe, Heather Flynn, Mark Law, Robert M. Arusell, Caterina Giannini, Karla V. Ballman, Hilary Blair, Robert B. Jenkins
Supplementary Tables 1-3 from A t(1;19)(q10;p10) Mediates the Combined Deletions of 1p and 19q and Predicts a Better Prognosis of Patients with Oligodendroglioma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04ee8a4d6b5842aaf1a456e23deefc0c
https://doi.org/10.1158/0008-5472.22365281
https://doi.org/10.1158/0008-5472.22365281
Autor:
Jan C. Buckner, Edward G. Shaw, Paul D. Brown, Sara Felten, Sandra Passe, Heather Flynn, Mark Law, Robert M. Arusell, Caterina Giannini, Karla V. Ballman, Hilary Blair, Robert B. Jenkins
Combined deletion of chromosomes 1p and 19q is associated with improved prognosis and responsiveness to therapy in patients with anaplastic oligodendroglioma. The deletions usually involve whole chromosome arms, suggesting a t(1;19)(q10;p10). Using s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31c0f63ba238195f9ac477baa21aa353
https://doi.org/10.1158/0008-5472.c.6494621
https://doi.org/10.1158/0008-5472.c.6494621
Autor:
Aarti K. Bhatia, Robert M. Arusell, Luis Baez-Diaz, Kishan J. Pandya, Ju Whei Lee, Charlotte Jacobs, George L. Adams, Seth A. Reiner, Eamonn Patrick Dunphy, Barbara Burtness, Philip Rubin, Shuli Li, Yi Li, Janardan D. Khandekar, Paul J. Limburg, Harlan A. Pinto, Paul Celano
Publikováno v:
Cancer. 123:4653-4662
BACKGROUND 13-Cis retinoic acid (13-CRA) is a synthetic vitamin A derivative. High-dose 13-CRA in patients with squamous cell cancers of the head and neck (SCCHNs) reduces the incidence of second primary tumors (SPTs). The authors report long-term re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52da48b9548b5e9ed13eec8138ca4d43
https://doi.org/10.1002/cncr.30920
https://doi.org/10.1002/cncr.30920
Autor:
Sara J. Felten, Wenting Wu, Thomas B. Daniels, Ross A. Abrams, Edward G. Shaw, Paul D. Brown, David Schiff, Walter J. Curran, Robert M. Arusell, Jan C. Buckner
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 81:218-224
A prognostic index for survival was constructed and validated from patient data from two European Organisation for Research and Treatment of Cancer (EORTC) radiation trials for low-grade glioma (LGG). We sought to independently validate this prognost
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11b80f5e54889287fb56d06b70382580
https://doi.org/10.1016/j.ijrobp.2010.05.003
https://doi.org/10.1016/j.ijrobp.2010.05.003
Autor:
Kurt A. Jaeckle, Caterina Giannini, Evanthia Galanis, Jan C. Buckner, Julie E. Hammack, Karla V. Ballman, Donald B. Wender, Joon H. Uhm, Paul D. Brown, Robert M. Arusell, Roscoe F. Morton, Paula J. Schomberg, Renee M. McGovern, Stephanie L. Safgren, Joel M. Reid, Daniel A. Nikcevich, Matthew M. Ames
Publikováno v:
Journal of Neuro-Oncology. 99:73-80
Irinotecan has radiosensitizing effects and shows synergism with nitrosoureas. We performed a Phase II study of RT and irinotecan, followed by BCNU plus irinotecan in newly-diagnosed GBM. The MTD for patients receiving enzyme-inducing anticonvulsants
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2a36754aa942deb43b8de62def0d23f
https://doi.org/10.1007/s11060-009-0103-2
https://doi.org/10.1007/s11060-009-0103-2
Autor:
William H. Yong, Joon H. Uhm, Robert M. Arusell, Paul S. Mischel, Paul D. Brown, J. N. Sarkaria, Kurt A. Jaeckle, Roscoe F. Morton, John W. Kugler, Francois J. Geoffroy, Sunil Krishnan, Bernd W. Scheithauer, Jan C. Buckner, Kendrith M. Rowland, Caterina Giannini, Robert B. Jenkins, Gaspar J. Kitange, Wenting Wu, David Schiff
Publikováno v:
Journal of Clinical Oncology. 26:5603-5609
Purpose Epidermal growth factor receptor (EGFR) amplification in glioblastoma multiforme (GBM) is a common occurrence and is associated with treatment resistance. Erlotinib, a selective EGFR inhibitor, was combined with temozolomide (TMZ) and radioth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4d27960eee5aa15dbf4f63766f9a5a8
https://doi.org/10.1200/jco.2008.18.0612
https://doi.org/10.1200/jco.2008.18.0612
Autor:
Jan C. Buckner, Karla V. Ballman, Robert M. Arusell, Matthew M. Clark, Teresa A. Rummans, Marlene H. Frost, Paul A. Decker, Paul D. Brown
Publikováno v:
American Journal of Clinical Oncology. 31:163-168
To examine whether a caregiver can provide reliable proxy quality of life (QOL) ratings of their adult significant other with a newly diagnosed high-grade glioma.This prospective QOL study was a companion protocol for 3 phase II high-grade glioma pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6189936a043f3d72068f1ec467538aad
https://doi.org/10.1097/coc.0b013e318149f1d3
https://doi.org/10.1097/coc.0b013e318149f1d3
Autor:
Jan C. Buckner, Nadia N. Laack, Karla V. Ballman, Paul D. Brown, Robert J. Ivnik, Robert M. Arusell, Alfred Furth, Edward G. Shaw, Julie E. Hammack
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 63:1175-1183
Purpose: To evaluate the effects of cranial radiotherapy (RT) on cognitive function in patients with supratentorial low-grade glioma. Methods and Materials: Twenty adult patients with supratentorial low-grade glioma were treated with 50.4 Gy (10 pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15660a421ca1f285191e3735d6a7e5ec
https://doi.org/10.1016/j.ijrobp.2005.04.016
https://doi.org/10.1016/j.ijrobp.2005.04.016
Autor:
Matthew M. Clark, Teresa A. Rummans, Bradley F. Boeve, Karla V. Ballman, Matthew J. Maurer, Robert M. Arusell, Jeff A. Sloan, Jan C. Buckner, Paul D. Brown, Bruce E. Pollock
Publikováno v:
Neurosurgery. 57:495-504
OBJECTIVE: To describe the quality of life (QOL) over time for adults with newly diagnosed high-grade gliomas and to examine the relationship between QOL and outcome data collected in three prospective cooperative group clinical trials. METHODS: The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::458f0129c7241d67530712d1e74228ae
https://doi.org/10.1227/01.neu.0000170562.25335.c7
https://doi.org/10.1227/01.neu.0000170562.25335.c7
Autor:
Burke J. Brooks, Steven E. Schild, Susan Geyer, Gist H. Farr, Muhammad Salim, Thomas G. Shanahan, Robert M. Arusell, James A. Mailliard, Henry D. Tazelaar, Francois J. Geoffroy, James E. Krook, James R. Jett, Randolph S. Marks, Shauna L. Hillman, Paul L. Schaefer, James A. Bonner
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 59:943-951
Purpose This Phase III study was performed to determine whether twice-daily (b.i.d.) radiotherapy (RT) resulted in better survival than once-daily (q.d.) RT for patients with limited-stage small-cell lung cancer (LD-SCLC). Methods and materials A tot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d266d87353c1867ba621dc1159726463
https://doi.org/10.1016/j.ijrobp.2004.01.055
https://doi.org/10.1016/j.ijrobp.2004.01.055